Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Long-Term Investments (2021 - 2024)

Pulmonx (LUNG) has disclosed Long-Term Investments for 4 consecutive years, with $4.3 million as the latest value for Q1 2024.

  • Quarterly Long-Term Investments rose 62.8% to $4.3 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Mar 2024, up 62.8% year-over-year, with the annual reading at $14.4 million for FY2023, 142.91% up from the prior year.
  • Long-Term Investments for Q1 2024 was $4.3 million at Pulmonx, down from $14.4 million in the prior quarter.
  • The five-year high for Long-Term Investments was $23.3 million in Q3 2023, with the low at $2.0 million in Q2 2021.
  • Average Long-Term Investments over 4 years is $7.7 million, with a median of $5.3 million recorded in 2022.
  • Peak annual rise in Long-Term Investments hit 165.88% in 2023, while the deepest fall reached 58.66% in 2023.
  • Over 4 years, Long-Term Investments stood at $10.9 million in 2021, then tumbled by 45.86% to $5.9 million in 2022, then soared by 142.91% to $14.4 million in 2023, then crashed by 70.17% to $4.3 million in 2024.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $4.3 million, $14.4 million, and $23.3 million for Q1 2024, Q4 2023, and Q3 2023 respectively.